Icon of the Instituts for Quality and Efficiency in Health Care

Rapid report

Exenatide in diabetes mellitus type 2 - Rapid report

Status
Status: Commission completed
Project no.
A05-23
Last updated

Report documents

  1. Executive summary of the rapid report

    Exenatide in diabetes mellitus type 2 - Rapid report

    published on
    Document type
    PDF document, 129 kB, EN, not accessible
    Download file : Executive summary of the rapid report (PDF document, 129 kB, EN, not accessible)

  2. Rapid Report

    Exenatide in diabetes mellitus type 2 - Rapid report

    published on
    Document type
    PDF document, 944 kB, DE, not accessible
    Download file : Rapid Report (PDF document, 944 kB, DE, not accessible)

Press releases

Benefit of exenatide has not yet been proven

No superiority versus the therapy alternative insulin regarding the lowering of blood glucose levels / Long-term effects unclear
Press release

Additional information

IQWiG health information

What medications help in type 2 diabetes?

Project details

Project no.
A05-23
Commission
Commission awarded on 17.11.2005 by the Federal Joint Committee (GBA).
Report type
Rapid report
Status
Commission completed
Department/Division
Drug Assessment
Topic
Digestion, metabolism and hormones

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page